Stock screenerAll disclosures →
EDGAR →
ZLAB
Conviction 6HealthcareScan · Thu, Jun 25, 2026ZLAB$18.53+0.84%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 1.11M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price18.53
Change+0.84%
Gap+1.06%
Rel volume1.11×
Avg volume1.07M
Avg $ vol18.71M
SMA 2017.60
SMA 5019.62
SMA 20021.57
Price vs 50-5.59%
Price vs 200-14.11%
MA stackbearish
50/200 cross—
Supertrenddown · 18.79
RSI (14)53
MACD hist0.26
MACD crossbull · 9d
Stoch %K / %D79 / 77
ADX (14)14
+DI / −DI24 / 22
RSI divergence—
MACD divergenceBullish
ATR %+4.27%
ADR %3.64%
52w high40.51
52w low16.30
From 52w high-54.27%
Above 52w low+13.65%
New 52w highNo
SqueezeOff
Bollinger width14.79%
%B0.85
Donchian pos79.47%
Donchian high19.11
Donchian low16.26
AVWAP (52w high)22.69
vs AVWAP high-18.35%
AVWAP (52w low)19.22
vs AVWAP low-3.64%
OBV trendUp
Chaikin MF (20)0.01
Today vs 20d1.11×
Avg vol (14d)1.11M
Avg vol (20d)1.07M
Avg $ vol (20d)18.71M
Market cap1.64B
RS 3m (vs SPY)-7.11%
RS 6m (vs SPY)-5.91%
RS line new highNo
Trend template0/8
Technical rank40.1
1 week+3.61%
1 month+0.41%
3 months+1.28%
6 months+4.60%
1 year-50.71%
YTD+6.90%
P/E-9.35
P/B2.48
P/S3.59
P/FCF-10.33
EPS-0.1600
Div yield—
ROE-26.52%
ROA-16.02%
Debt/Eq0.32
Current2.40
EV/EBITDA-5.61
Gross margin—
Net margin-38.40%
Rev growth14.98%
EPS growth31.72%
Price target32.40
Target upside74.90%
Analyst ratingBuy
Institutional24.90%
Ent. value1.2B
Revenue95.56M
Net income-51.02M
Gross profit—
Free cash flow-158.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out113.41M
Employees1.8K
ListedWed, Sep 20, 2017
Free float88.59M
Float %100.0%
Short interest6.53M
Days to cover8.5d
Short volume73.9%
Squeeze score61 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast—
Last EPS vs est−$0.46 vs −$0.58
Last surprise+20.7% beat
Setup gradeD
Conviction6 / 100
Pattern quality—
Tech rank40.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance20.26
Support16.28
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ZLAB
No recent disclosed trades by Congress in ZLAB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ZLAB · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Vounatsos Michel Director · American Depositary Shares · 2026-06-17 | Grant | 22.37K | — | 2026-06-17 | 2026-06-22 |
WIRTH PETER Director · American Depositary Shares · 2026-06-17 | Grant | 22.37K | — | 2026-06-17 | 2026-06-22 |
DIEKMAN JOHN D Director · American Depositary Shares · 2026-06-17 | Grant | 22.37K | — | 2026-06-17 | 2026-06-22 |
Leung Nisa Director · American Depositary Shares · 2026-06-17 | Grant | 22.37K | — | 2026-06-17 | 2026-06-22 |
GAYNOR RICHARD Director · American Depositary Shares · 2026-06-17 | Grant | 22.37K | — | 2026-06-17 | 2026-06-22 |
Morrison Scott W Director · American Depositary Shares · 2026-06-17 | Grant | 22.37K | — | 2026-06-17 | 2026-06-22 |
Lis William Director · American Depositary Shares · 2026-06-17 | Grant | 22.37K | — | 2026-06-17 | 2026-06-22 |
MOULDER LEON O JR Director · American Depositary Shares · 2026-06-17 | Grant | 22.37K | — | 2026-06-17 | 2026-06-22 |
Wang Yizhe Operating Partner · Stock Option (Right to Buy) · 2026-05-11 | Grant | 136.82K | $0 | 2026-05-11 | 2026-06-08 |
Wang Yizhe Operating Partner · Restricted Share Units · 2026-05-11 | Grant | 59.29K | $0 | 2026-05-11 | 2026-06-08 |
SEC filings
EDGAR filings in ZLAB · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.